Immunotherapy for superficial bladder cancer. A developmental and clinical overview.
about
Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokinesMycobacterium bovis BCG producing interleukin-18 increases antigen-specific gamma interferon production in mice.A novel method for monitoring Mycobacterium bovis BCG trafficking with recombinant BCG expressing green fluorescent protein.Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes.
P2860
Immunotherapy for superficial bladder cancer. A developmental and clinical overview.
description
1992 nî lūn-bûn
@nan
1992 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Immunotherapy for superficial bladder cancer. A developmental and clinical overview.
@ast
Immunotherapy for superficial bladder cancer. A developmental and clinical overview.
@en
type
label
Immunotherapy for superficial bladder cancer. A developmental and clinical overview.
@ast
Immunotherapy for superficial bladder cancer. A developmental and clinical overview.
@en
prefLabel
Immunotherapy for superficial bladder cancer. A developmental and clinical overview.
@ast
Immunotherapy for superficial bladder cancer. A developmental and clinical overview.
@en
P1476
Immunotherapy for superficial bladder cancer. A developmental and clinical overview.
@en
P2093
P304
P577
1992-08-01T00:00:00Z